Conclusion

In this document, we looked at different viewpoints on the issue of biotechnology crops. Most of the authors agree that biotechonology crops have potential when targeted to specific situations. Experts in the biotechnology field have invested a lot of time and money developing biotech varities of crops. But, farmers and consumers are a big part of the overall adoption of biotech around the world.

Biotechnology does have its issues as highlighted by Peter Rosset and Miguel Altieri who say that use of GM crops has not benfited poor farmers. Countries that recognize the risk the environment and human health have not accepted biotech and some poor countries are rejected food aid that consists of GM food. Regulations in European Union have slowed down the adoption of GM crops with countries choosing only certain traits to plant. To really take advantage of biotechnology efforts should target the fundamental problems of not having food in the first place.

Consumers are looking for alternatives from biotech food and the recent rise in organic food trends is an indication of that. Labeling is a key issue in biotech with consumers identifying the true risks of biotech crops. Froma Harrop's article also cites a ABC News Poll that showed a large amount of consumers want food to be labelled. Health conscious consumers already have nutrition lables and designating GM or non-GM can be a routine process. The final product that reaches the consumer will signal acceptance of GM foods and food producers will be actively purusing healthier ingredients.